Sabby Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Sabby Management’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-931,414	Closed	-$2.95M	–	207
2021 Q2	$2.95M	Sell	931,414 -1,369,647	-60%	-$3.42M	0.42%	31
2021 Q1	$7.48M	Buy	+2,301,061	New	+$8.33M	1.46%	12
2020 Q2	–	Sell	-1,760,262	Closed	-$850K	–	128
2020 Q1	$619K	Buy	+1,760,262	New	+$1.84M	0.26%	35
2018 Q2	–	Sell	-19,747	Closed	-$436K	–	189
2018 Q1	$436K	Sell	19,747 -34,722	-64%	-$794K	0.05%	98
2017 Q4	$1.37M	Buy	+54,469	New	+$1.68M	0.12%	60
2017 Q3	–	Sell	-266,103	Closed	-$3.1M	–	216
2017 Q2	$2.46M	Buy	+266,103	New	+$2.53M	0.16%	63
2016 Q1	–	Sell	-117,039	Closed	-$5.01M	–	359
2015 Q4	$3.77M	Sell	117,039 -5,355	-4%	-$172K	0.21%	76
2015 Q3	$3.6M	Sell	122,394 -7,283	-6%	-$270K	0.15%	105
2015 Q2	$5.06M	Buy	+129,677	New	+$5.97M	0.18%	91

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Sabby Management's ASXC Position: Q3 2021 in Review

Sabby Management sold out of Asensus Surgical, Inc. (ASXC) in Q3 2021, closing a stake of 931,414 shares — an estimated $2.95M sold.

Sabby Management first reported a position in ASXC in Q2 2015 and held it in 9 quarters. The position peaked at $7.48M in Q1 2021. 111 funds tracked by Wall St. Rank hold ASXC as of Q3 2021.

Sabby Management reported no remaining Asensus Surgical, Inc. position as of Q3 2021 after selling out during the quarter.
Sabby Management sold 931,414 Asensus Surgical, Inc. shares in Q3 2021, an estimated $2.95M.
Sabby Management first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 9 quarters.
Sabby Management's Asensus Surgical, Inc. position peaked at $7.48M in Q1 2021.
111 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2021.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.